Showing results (31-40 of 88) with videos related to
Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|December 12, 2013
Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcomaMikell Paige, George Kosturko, Güllay Bulut, et al.Journal of Medicinal Chemistry|July 10, 2008
Asymmetric synthesis of 2,3-dihydro-2-arylquinazolin-4-ones: methodology and application to a potent fluorescent tubulin inhibitor with anticancer activityGary M Chinigo, Mikell Paige, Scott Grindrod, et al.Journal of Medicinal Chemistry|February 27, 2010
Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograftKathryn D Sheikh, Partha P Banerjee, Shankar Jagadeesh, et al.Chemistry & Biology|September 27, 2005
Structure-based discovery of a boronic acid bioisostere of combretastatin A-4Yali Kong, Jolanta Grembecka, Michael C Edler, et al.Antioxidants (Basel, Switzerland)|October 26, 2024
Exploring Angiotensin II and Oxidative Stress in Radiation-Induced Cataract Formation: Potential for Therapeutic InterventionVidya P Kumar, Yali Kong, Riana Dolland, et al.Oncotarget|November 16, 2017
Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumorHyo Jin Kang, Yong Weon Yi, Shu-Jie Hou, et al.Scientific Reports|October 14, 2025
A novel D-peptide modulates DCLK1 gelsolin interactions, reducing PDAC tumor growthLandon L Moore, Dongfeng Qu, Parthasarathy Chandrekesan, et al.Proceedings of the National Academy of Sciences of the United States of America|January 5, 2013
STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domainOlga A Timofeeva, Nadya I Tarasova, Xueping Zhang, et al.Tissue Engineering|August 8, 2006
Small molecule inducers of angiogenesis for tissue engineeringKristen A Wieghaus, Scott M Capitosti, Christopher R Anderson, et al.Clinical Prostate Cancer|March 26, 2004
Therapeutic approaches targeting prostate cancer progression using novel voltage-gated ion channel blockersRobert A Sikes, Alison M Walls, W Nathaniel Brennen, et al.Pageof 9